We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Targeting the Engine Room of the Cancer Cell

News   Jun 19, 2018 | Original story from Columbia University Irving Medical Center (CUIMC)

 
Targeting the Engine Room of the Cancer Cell

The pipeline consists of a series of pre-computed (*) components, including a reference set of more than 13,000 tumor expression profiles representing 35 different tumor types, a collection of 28 tissue context-specific interactomes and a database of context-specific mechanism of action (MoA) for >400 FDA-approved drugs and investigational compounds in oncology. The transcriptome of the perturbed cell lines is profiled at low cost by PLATE-Seq. The process begins with the expression profile of a single patient sample, which is compared against the tumor databank to generate a tumor gene expression signature. This signature is interpreted by VIPER using a context-matched interactome to identify the set of most dysregulated proteins, which constitute the regulators of the tumor cell state -- tumor checkpoint. These proteins are then aligned against the drugs' and compounds' MoA database, to prioritize compounds able to invert the activity pattern of the tumor checkpoint. Credit: CUIMC/Califano Lab

 
 
Advertisement
 

RELATED ARTICLES

Common Diabetes Drugs May Help Prevent Parkinson’s Disease, Large Study Finds

News

Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by UCL researchers.

READ MORE

Alterations in Subcellular Traffic Increases Invasiveness of Radioresistant Cancer Cells

News

Scientists have revealed the molecular mechanism regulating the trafficking of lysosomes that increases the invasiveness of radioresistant cancer cells following radiotherapy.

READ MORE

Nanobiologic Approach Trains the Innate Immune System To Eliminate Tumor Cells

News

A novel type of cancer immunotherapy trains the innate immune system to help it eliminate cancer cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are partnered with a therapeutic component.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE